Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-22
2006-08-22
Fredman, Jeffrey (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100
Reexamination Certificate
active
07094534
ABSTRACT:
Disclosed are new methods comprising the use of in situ hybridization to detect abnormal nucleic acid sequence copy numbers in one or more genomes wherein repetitive sequences that bind to multiple loci in a reference chromosome spread are either substantially removed and/or their hybridization signals suppressed. The invention termed Comparative Genomic Hybridization (CGH) provides for methods of determining the relative number of copies of nucleic acid sequences in one or more subject genomes or portions thereof (for example, a tumor cell) as a function of the location of those sequences in a reference genome (for example, a normal human genome). The intensity(ies) of the signals from each labeled subject nucleic acid and/or the differences in the ratios between different signals from the labeled subject nucleic acid sequences are compared to determine the relative copy numbers of the nucleic acid sequences in the one or more subject genomes as a function of position along the reference chromosome spread. Amplifications, duplications and/or deletions in the subject genome(s) can be detected. Also provided is a method of determining the absolute copy numbers of substantially all RNA or DNA sequences in subject cell(s) or cell population(s).
REFERENCES:
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4647529 (1987-03-01), Rodland et al.
patent: 4681840 (1987-07-01), Stephenson et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4707440 (1987-11-01), Stavrianopoulos
patent: 4710465 (1987-12-01), Weissman et al.
patent: 4711955 (1987-12-01), Ward et al.
patent: 4721669 (1988-01-01), Barton
patent: 4725536 (1988-02-01), Fritsch et al.
patent: 4770992 (1988-09-01), Van den Engh et al.
patent: 4772691 (1988-09-01), Herman
patent: 4888278 (1989-12-01), Singer et al.
patent: 5085983 (1992-02-01), Scanlon
patent: 5427932 (1995-06-01), Weier et al.
patent: 5447841 (1995-09-01), Gray et al.
patent: 5472842 (1995-12-01), Stokke et al.
patent: 5665549 (1997-09-01), Pinkel et al.
patent: 5721098 (1998-02-01), Pinkel et al.
patent: 5856097 (1999-01-01), Pinkel et al.
patent: 5965362 (1999-10-01), Pinkel et al.
patent: 5976790 (1999-11-01), Pinkel et al.
patent: 6159685 (2000-12-01), Pinkel et al.
patent: 6335167 (2002-01-01), Pinkel et al.
patent: 0430402 (1991-06-01), None
patent: 2019408 (1979-10-01), None
patent: 2215724 (1989-09-01), None
patent: 87/05027 (1987-08-01), None
patent: 90/05789 (1990-05-01), None
Bloomfield et al, “Nonrandom chormosome abnormalities in lymophoma”, Cancer Research (1983) 43:2975-2984.
Alitalo et al, “Homogenously staining chromosomal regions containing amplified copies of an abundantly expresses cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma”, Proc. Natl. Acad. Sci. (1983) 80:1707-1711.
Hainsworth et al, “Cytogenetic features of twenty six primary breast cancers”, Cancer Genet. Cytogenet. (1991) 52:205-218.
Tsuda et al, “Correlation between long term survival in Breast Cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear1”, Cancer Research (1989) 49:3104-3108.
Lavialle et al (Anticancer Research (1989) 9:1265-1280).
Albertson, “Mapping Muscle Protein Genes byin situHybridization Using Biotin-Labeled Probes,”EMBO J., vol. 4, No. 10, 1985, pp. 2493-2498.
Albertson, “Localization of the Ribosomal Genes inCaenorhabditis elegansChromosomes byin situHybridization Using Biotin-Labeled Probes,”EMBO J., vol. 3, No. 6, 1984, pp. 1227-1234.
Alitalo et al, “Homogenously staining chromosomal regions containing amplified copies of abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma,”Proc. Natl. Acad. Sci., vol. 80, Mar. 1983, pp. 1707-1711.
Angerer et al, “In SituHybridization to Cellular RNAs,”Genetic Engineering: Principles and Methods, Setlow and Hollaender, Eds., vol. 7, pp. 43-65, Plenum Press, New York (1985).
Ardeshir et al, “Structure of Amplified DNA in Different Syrian Hamster Cell Lines Resistant toN- (Phosphonacetyl)-L-Aspartate,”Molecular and Cellular Biology, vol. 3, No. 11, Nov. 1983, pp. 2076-2088.
Arnoldus et al, “Detection of the Philadelphia Chromosome in Interphase Nuclei (With 2 Color Plates),”Cytogenet. Cell Genet., vol. 54, 1990, pp. 108-111.
Babu et al, “Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology,”Cancer Res., vol. 47, Dec. 1987, pp. 6800-6805.
Bar-Am et al, “Detection of Amplified DNA Sequences in Human Tumor Cell Lines by Fluorescence In Situ Hybridization,”Genes, Chromosomes&Cancer, vol. 4, 1992, pp. 314-320.
Bayer et al, “The Use of the Avidin-Biotin Complex as a Tool in Molecular Biology,”Methods of Biochemical Analysis, vol. 26, pp. 1-45 (1980).
Benton et al, “Screening λgt Recombinant Clones by Hybridization to Single Plaquesin situ,” Science, vol. 196, 1977, pp. 180-182.
Bergerheim et al, “Deletion Mapping in Human Renal Cell Carcinoma,”Cancer Res., vol. 49, Mar. 1989, pp. 1390-1396.
Bookstein et al, “Human Retinoblastoma Susceptibility Gene: Genomic Organization and Analysis of Heterozygous Intragenic Deletion Mutants,”PNAS(USA), vol. 85, Apr. 1988, pp. 2210-2214.
Boyle et al, “Differential Distribution of Long and Short Interspersed Element Sequences in the Mouse Genome: Chromosome Karyotyping by Fluorescencein situHybridization,”PNAS Sci. USA, vol. 87, 1990, pp. 7757-7761.
Brigati et al, “Detection of Viral Genomes in Cultured Cells and Paraffin-Embedded Tissue Sections Using Biotin-Labeled Hybridization Probes,”Virology, vol. 126, pp. 32-50 (1983).
Brison et al, “General Method for Cloning Amplified DNA by Differential Screening with Genomic Probes,”Molecular and Cellular Biology, vol. 2, No. 5, May 1982, pp. 578-587.
Britten et al, “Analysis of Repeating DNA Sequences by Reassociation,”Methods of Enzymology, vol. 29, 1974, pp. 363-418.
Brock et al., Quantitative in situ Hybridization Reveals Extent of Sequence Homology Between Related DNA Sequences inDrosophila melanogaster, CHROMOSOMA, vol. 83, No. 2, 1981, pp. 159-168.
Broker et al., “Electron Microscopic Visualization of tRNA Genes with Ferritin-Avidin: Biotin Labels,”Nucleic Acids Research, vol. 5, No. 2, pp. 363-384 (1978).
Bufton et al, “A Highly Polymorphic Locus On Chromosome 16q Revealed By A Probe From A Chromosome-Specific Cosmid Library,”Human Genetics, vol. 74, 1986, pp. 425-431.
Bufton et al, “Four Restriction Fragment Length Polymorphisms Revealed By Probes From A Single Cosmid Map To Human Chromosome 19,”Am J Hum Genet, vol. 38, 1986, pp. 447-460.
Buongiorno-Nardelli et al, “Autoradiographic Detection of Molecular Hybrids between rRNA and DNA in Tissue Sections,”NATURE, vol. 225, Mar. 1970, pp. 946-948.
Burk et al, “Organization and Chromosomal Specificity of Autosomal Homologs of Human Y Chromosome Repeated DNA,”Chromosoma, vol. 92, 1985, pp. 225-233.
Buroker et al, “Four Restriction Fragment Length Polymorphisms Revealed By Probes From A Single Cosmid Map To Human Chromosome 12q,”Human Genetics, vol. 72, 1986, pp. 86-94.
Cannizzaro et al, “In Situ Hybridization and Translocation Breakpoint Mapping II. Two Unusual t(21;22) Translocations,”Cytogenet. Cell Genet., vol. 39, 1985, pp. 173-178.
Cantor et al, “The Behavior of Biological Macromolecules, Part III,”Biophysical Chemistry, Freeman & Co. 1980, pp. 1183, 1226-1228.
Cassidy et al, “Deletion of chromosome 15(q11-13) in a Prader-Labhart-Willi syndrom clinic population,”Am. J. Med. Genet., vol. 17, 1984, pp. 485-495.
Cohen et al, “Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation,”N. Engl. J.
Gray Joe W.
Kallioniemi Anne
Kallioniemi Ollie-Pekka
Pinkel Daniel
Sakamoto Masaru
Fredman Jeffrey
Haliday Emily M.
Quine I.P. Law Group P.C.
The Regents of the University of California
LandOfFree
Detection of chromosoal abnormalities associated with breast... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of chromosoal abnormalities associated with breast..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of chromosoal abnormalities associated with breast... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701963